Education Library

At TCT 2022, Jonathan Hill, MD, presents the influential high-risk PCI trials shaping the future of ischemic heart failure therapy.

At TCT 2022, Jonathan Hill, MD, presents the influential high-risk PCI trials shaping the future of ischemic heart failure therapy.

Junya Ako, MD, presents outcomes in AMI cardiogenic shock from Japan’s J-PVAD study at TCT 2022.

Robert Yeh, MD, discusses how we analyze data, make treatment decisions and participate in developing clinical evidence.

Gregg Stone, MD, FACC, FSCAI interviews Prof. Divaka Perera, professor of cardiology at Kings College in London, UK at the European Society of Cardiology (ESC) Congress 2022 in Barcelona, Spain. Dr.

Aditya Bharadwaj, MD, an investigator for the RESTORE EF study, presents a case study epitomizing the results from the trial.

Mitul Patel, MD, discusses the RESTORE EF study and a successful case of improved ejection fraction with complete revascularization.

Jason Wollmuth, MD, describes best practice techniques for Impella-supported complete revascularization in a RESTORE EF case.

Arman Kilic, MD, discusses his experiences with collaboration between interventional cardiology and cardiac surgery, particularly regarding Impella 5.5® with SmartAssist® and ECpella™.

Navin Kapur, MD, discusses the latest science underlying reperfusion and unloading and how it led to the STEMI-DTU pilot and pivotal trials.

Bobby Yeh, MD, discusses how real-world evidence factors into treatment decisions made every day in clinical practice.

Federico Pappalardo, MD, describes the role of IABP in the treatment of acute-on-chronic heart failure complicated by cardiogenic shock. 

Mario Iannaccone, MD and Vasileios Panoulas, MD, discuss two meta-analyses demonstrating improved survival in cardiogenic shock managed with ECMO and Impella (ECpella™) versus ECMO alone.

Charles Simonton, MD, interviews Prof. Norman Mangner, MD, from Dresden Heart Center, about the rollout of the PROTECT IV trial. The interview focuses on an update on the PROTECT IV trial in light of the upcoming Investigator Meeting at the EuroPCR in Paris in May 2022.

The focus of the interview between Charles Simonton, MD, and PD Fadi Al-Rashid, MD, is an update on the STEMI DTU trial in light of the investigator meeting at EuroPCR in Paris in May 2022.